Literature DB >> 7987324

Angelman syndrome associated with a maternal 15q11-13 deletion of less than 200 kb.

J L Buxton1, C T Chan, H Gilbert, J Clayton-Smith, J Burn, M Pembrey, S Malcolm.   

Abstract

Angelman syndrome (AS) is a neurogenetic disorder arising from a lack of genetic contribution from the maternal chromosome 15q11-13. To date, the AS critical region has been defined by an inherited deletion of approximately 1.5Mb, spanning the 3-21 (D15S10), LS6-1 (D15S113) and GABRB3 loci. We have identified an individual with the typical features of AS who has a deletion of the maternal chromosome which encompasses LS6-1, but does not extend to either flanking marker. This deletion, initially detected by (CA)n repeat analysis, was further characterised by fluorescence in situ hybridisation (FISH) using cosmids derived from a 260 kb LS6-1 yeast artificial chromosome (YAC). Neither end cosmid from this YAC clone falls within the deletion, suggesting that the minimal AS region is less than 200 kb. We also studied three loci within 15q11-13 which detect parent-of-origin specific DNA methylation imprints, and found that both normal maternal and paternal patterns were present in this patient.

Entities:  

Mesh:

Year:  1994        PMID: 7987324     DOI: 10.1093/hmg/3.8.1409

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  6 in total

1.  Counselling dilemmas associated with the molecular characterisation of two Angelman syndrome families.

Authors:  H L Gilbert; J L Buxton; C T Chan; T McKay; S Cottrell; S Ramsden; R M Winter; M E Pembrey; S Malcolm
Journal:  J Med Genet       Date:  1997-08       Impact factor: 6.318

2.  Familial cryptic translocation resulting in Angelman syndrome:implications for imprinting or location of the Angelman gene?

Authors:  L W Burke; J E Wiley; C C Glenn; D J Driscoll; K M Loud; A J Smith; T Kushnick
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

3.  Molecular analysis of 36 mutations at the mouse pink-eyed dilution (p) locus.

Authors:  D K Johnson; L J Stubbs; C T Culiat; C S Montgomery; L B Russell; E M Rinchik
Journal:  Genetics       Date:  1995-12       Impact factor: 4.562

4.  The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region.

Authors:  J S Sutcliffe; Y H Jiang; R J Galijaard; T Matsuura; P Fang; T Kubota; S L Christian; J Bressler; B Cattanach; D H Ledbetter; A L Beaudet
Journal:  Genome Res       Date:  1997-04       Impact factor: 9.043

5.  Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients.

Authors:  S L Christian; W P Robinson; B Huang; A Mutirangura; M R Line; M Nakao; U Surti; A Chakravarti; D H Ledbetter
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

6.  Routine screening for microdeletions by FISH in 77 patients suspected of having Prader-Willi or Angelman syndromes using YAC clone 273A2 (D15S10).

Authors:  M Erdel; S Schuffenhauer; B Buchholz; U Barth-Witte; S Köchl; B Utermann; H C Duba; G Utermann
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.